Pharmacological Screening of Glycine Amino Acid Prodrug of Acetaminophen

Overview

Journal Indian J Pharmacol

Specialty Pharmacology

Date 2015 Apr 17

PMID 25878383

Citations 3

Authors

Arun Parashar

Affiliations

Soon will be listed here.

Abstract

Objective: To develop an amino acid prodrug of acetaminophen with comparable therapeutic profile and less hepatotoxicity than acetaminophen.

Materials And Methods: Acetaminophen prodrug was synthesized by esterification between the carboxyl group of amino acid glycine and hydroxyl group of acetaminophen. Analgesic, antipyretic, ulcer healing, and hepatotoxic activities were performed on Wistar rats in this study.

Results: Prodrug showed a 44% inhibition in writhings as compared to 53.3% of acetaminophen. Acetaminophen also offered highest antipyretic activity. Prodrug showed gastroprotective and hepatoprotective effects as it reduced the gastric lesions by 32.1% (P < 0.01) and significantly prevented the rise in liver enzymes (serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase and bilirubin). The most notable effect of prodrug was in preventing the depletion of hepatic glutathione (GSH), which is reduced by acetaminophen.

Conclusion: Prodrug showed hepatoprotective and gastroprotective effects, although the therapeutic efficacy was compromised. Prodrug was successful in preventing a decrease in GSH, thereby exhibiting promising results in the field of prodrug designing to avoid the toxic effects of acetaminophen.

Citing Articles

Exploring acetaminophen prodrugs and hybrids: a review.

Kouznetsov V RSC Adv. 2024; 14(14):9691-9715.

PMID: 38525062 PMC: 10958773. DOI: 10.1039/d4ra00365a.

An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact.

Mallet C, Desmeules J, Pegahi R, Eschalier A J Pain Res. 2023; 16:1081-1094.

PMID: 37016715 PMC: 10066900. DOI: 10.2147/JPR.S393809.

Perinatal Acetaminophen Exposure and Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Exploring the Role of Umbilical Cord Plasma Metabolites in Oxidative Stress Pathways.

Anand N, Raghavan R, Wang G, Hong X, Azuine R, Pearson C Brain Sci. 2021; 11(10).

PMID: 34679367 PMC: 8533963. DOI: 10.3390/brainsci11101302.

References

Daly F, Fountain J, Murray L, Graudins A, Buckley N . Guidelines for the management of paracetamol poisoning in Australia and New Zealand--explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust. 2008; 188(5):296-301. DOI: 10.5694/j.1326-5377.2008.tb01625.x. View

Thomas J, Sloan K . In vitro evaluation of alkylcarbonyloxymethyl (ACOM) ethers as novel prodrugs of phenols for topical delivery: ACOM prodrugs of acetaminophen. Int J Pharm. 2007; 346(1-2):80-8. DOI: 10.1016/j.ijpharm.2007.06.007. View

Kristensen D, Hass U, Lesne L, Lottrup G, Jacobsen P, Desdoits-Lethimonier C . Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod. 2010; 26(1):235-44. DOI: 10.1093/humrep/deq323. View

Alander S, Dowd M, Bratton S, Kearns G . Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med. 2000; 154(4):346-50. DOI: 10.1001/archpedi.154.4.346. View

James L, Mayeux P, Hinson J . Acetaminophen-induced hepatotoxicity. Drug Metab Dispos. 2003; 31(12):1499-506. DOI: 10.1124/dmd.31.12.1499. View

Wasdo S, Sloan K . Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen. Pharm Res. 2004; 21(6):940-6. DOI: 10.1023/b:pham.0000029281.12753.25. View

Watson W, Litovitz T, Klein-Schwartz W, Rodgers Jr G, Youniss J, Reid N . 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004; 22(5):335-404. DOI: 10.1016/j.ajem.2004.06.001. View

Boyer T, Rouff S . Acetaminophen-induced hepatic necrosis and renal failure. JAMA. 1971; 218(3):440-1. View

Hussain A, Kulkarni P, Perrier D . Prodrug approaches to enhancement of physicochemical properties of drugs IX: acetaminophen prodrug. J Pharm Sci. 1978; 67(4):545-6. DOI: 10.1002/jps.2600670426. View

10.

Dahlin D, Nelson S . Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. J Med Chem. 1982; 25(8):885-6. DOI: 10.1021/jm00350a001. View

11.

Henretig F, Selbst S, Forrest C, Kearney T, OREL H, Werner S . Repeated acetaminophen overdosing. Causing hepatotoxicity in children. Clinical reports and literature review. Clin Pediatr (Phila). 1989; 28(11):525-8. DOI: 10.1177/000992288902801107. View

12.

Vermeulen N, Bessems J, van de Straat R . Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab Rev. 1992; 24(3):367-407. DOI: 10.3109/03602539208996298. View

13.

Rowden A, Norvell J, Eldridge D, Kirk M . Updates on acetaminophen toxicity. Med Clin North Am. 2005; 89(6):1145-59. DOI: 10.1016/j.mcna.2005.06.009. View

14.

Larson A, Polson J, Fontana R, Davern T, Lalani E, Hynan L . Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005; 42(6):1364-72. DOI: 10.1002/hep.20948. View

15.

Majumdar S, Sloan K . Synthesis, hydrolyses and dermal delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) derivatives of phenol, imide and thiol containing drugs. Bioorg Med Chem Lett. 2006; 16(13):3590-4. DOI: 10.1016/j.bmcl.2006.03.061. View

16.

Hawkins L, Edwards J, Dargan P . Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature. Drug Saf. 2007; 30(6):465-79. DOI: 10.2165/00002018-200730060-00002. View

17.

Wu Z, Patel A, Dave R, Yuan X . Development of acetaminophen proline prodrug. Bioorg Med Chem Lett. 2010; 20(13):3851-4. DOI: 10.1016/j.bmcl.2010.05.050. View